Natural product-inspired fragment-based drug discovery: Development of M. tuberculosis CYP121 inhibitors

被引：0
|
作者：
Kavanagh, Madeline [1 ]
Gray, Janine [1 ]
Coyne, Anthony [1 ]
Davis, Holly [1 ]
McLean, Kirsty [2 ]
Munro, Andrew [2 ]
Abell, Christopher [1 ]
机构：
[1] Univ Cambridge, Dept Chem, Cambridge, England
[2] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
818
引用
收藏
页数：2
相关论文
共 50 条
  • [31] From Natural Product-Inspired Pyrrolidine Scaffolds to the Development of New Human Golgi α-Mannosidase II Inhibitors
    Cheng, Ting-Jen R.
    Chan, Ting-Hao
    Tsou, En-Lun
    Chang, Shang-Yu
    Yun, Wen-Yi
    Yang, Pei-Jung
    Wu, Ying-Ta
    Cheng, Wei-Chieh
    CHEMISTRY-AN ASIAN JOURNAL, 2013, 8 (11) : 2600 - 2604
  • [32] Development of inhibitors for Mycobacterium tuberculosis pantothenate synthetase using a fragment-based approach
    Hung, Alvin W.
    Silvestre, Leonardo
    Ciulli, Alessio
    Wen, Shijun
    Blundell, Tom L.
    Abell, Chris
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238 : 698 - 698
  • [33] Development of Computational Approaches with a Fragment-Based Drug Design Strategy: In Silico Hsp90 Inhibitors Discovery
    Leon, Roberto
    Soto-Delgado, Jorge
    Montero, Elizabeth
    Vargas, Matias
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [34] Aminoindazole PDK1 Inhibitors: A Case Study in Fragment-Based Drug Discovery
    Medina, Jesus R.
    Blackledge, Charles W.
    Heerding, Pirk A.
    Campobasso, Nino
    Ward, Paris
    Briand, Jacques
    Wright, Lois
    Axten, Jeffrey M.
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (08): : 439 - 442
  • [35] Fragment-based drug discovery of potent and selective MKK3/6 inhibitors
    Bigi, Simone
    Adams, Mark
    Kobayashi, Toshitake
    Lawson, David
    Saitoh, Morihisa
    Shimagawa, Kenichiro
    Hixon, Mark
    Smith, Chris
    Tatamiya, Takayuki
    Goto, Masayuki
    Russo, Joseph
    Grimshaw, Ched
    Swann, Steve
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [36] Fragment-based drug discovery of potent and selective MKK3/6 inhibitors
    Adams, Mark
    Kobayashi, Toshitake
    Lawson, J. David
    Saitoh, Morihisa
    Shimokawa, Kenichiro
    Bigi, Simone V.
    Hixon, Mark S.
    Smith, Christopher R.
    Tatamiya, Takayuki
    Goto, Masayuki
    Russo, Joseph
    Grimshaw, Charles E.
    Swann, Steven
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (03) : 1086 - 1089
  • [37] Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story
    Stamford, Andrew
    Strickland, Corey
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2013, 17 (03) : 320 - 328
  • [38] Fragment-based drug discovery of carbonic anhydrase II inhibitors by dynamic combinatorial chemistry
    Edwards, Paul
    DRUG DISCOVERY TODAY, 2007, 12 (11-12) : 497 - 498
  • [39] Fragment-based drug discovery of selective inhibitors of fibroblast growth factor receptor (FGFr)
    Saxty, Gordon
    Squires, M. S.
    Murray, C. W.
    Berdini, V.
    Ward, G. A.
    Miller, D.
    Rich, S. J.
    Cleasby, A.
    Saalau-Bethell, S. M.
    Coyle, J.
    Madin, A.
    Carr, M. G.
    O'Brien, M. A.
    Jones, C. Griffiths
    Vickerstaff, E.
    Nijjar, R. K.
    Graham, B.
    Pike, A.
    Lewis, E. J.
    Perera, T.
    Angibaud, P.
    Newell, H.
    CANCER RESEARCH, 2010, 70
  • [40] Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery
    Zech, Stephan G.
    Kohlmann, Anna
    Zhou, Tianjun
    Li, Feng
    Squillace, Rachel M.
    Parillon, Lois E.
    Greenfield, Matthew T.
    Miller, David P.
    Qi, Jiwei
    Thomas, R. Mathew
    Wang, Yihan
    Xu, Yongjin
    Miret, Juan J.
    Shakespeare, William C.
    Zhu, Xiaotian
    Dalgarno, David C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (02) : 671 - 686
12345